CAH
Cardinal Health, Inc.

3,242
Loading...
Loading...
News
all
press releases
Should You Hold STERIS Stock in Your Portfolio Right Now?
STE posts solid Healthcare and AST growth with strong liquidity but faces macroeconomic and currency headwinds.
Zacks·9h ago
News Placeholder
More News
News Placeholder
Is Quest Diagnostics Stock a Right Pick for Your Portfolio Now?
DGX posts strong gains from physician and hospital channels while advancing AI-powered solutions.
Zacks·1d ago
News Placeholder
Should Value Investors Buy Cardinal Health (CAH) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks·4d ago
News Placeholder
Is it the Right Time to Retain Abbott Stock in Your Portfolio?
ABT's strong Nutrition, Diabetes Care and EPD growth fuel momentum, but macro and currency headwinds challenge its outlook.
Zacks·5d ago
News Placeholder
Here's Why Cardinal Health (CAH) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks·6d ago
News Placeholder
CAH Strengthens Distribution With New Consumer Health Logistics Hub
Cardinal Health opens a 350,000-square-foot Consumer Health Logistics Center in Ohio, strengthening its pharmaceutical supply chain and advancing its multiyear infrastructure expansion strategy.
Zacks·6d ago
News Placeholder
The New Olink Target 48 Neurodegeneration Panel May Boost TMO Stock
Thermo Fisher unveils the Olink Target 48 Neurodegeneration panel to accelerate biomarker research in neurodegenerative diseases.
Zacks·7d ago
News Placeholder
Should You Continue to Hold Integra Stock in Your Portfolio Now?
IART shows strong demand in neurosurgery and Tissue Technologies but faces macro and liquidity challenges.
Zacks·7d ago
News Placeholder
Cardinal Health (CAH) Stock Sinks As Market Gains: Here's Why
Cardinal Health (CAH) reached $150.27 at the closing of the latest trading day, reflecting a -1.29% change compared to its last close.
Zacks·8d ago
News Placeholder
Is Cardinal Health (CAH) Stock Outpacing Its Medical Peers This Year?
Here is how Cardinal Health (CAH) and Adaptive Biotechnologies (ADPT) have performed compared to their sector so far this year.
Zacks·13d ago

Latest CAH News

View

Advertisement. Remove ads.

Advertisement. Remove ads.